< Back to Newsletter Archive

BIO Newsletter
BIO Newsletter: BIO Newsletter: BIO Investor Forum Concludes, Blaming Pharma Won’t Lower Health Care Costs
SUBSCRIBE | VIEW ONLINE 10.20.2017
BIO NEWSLETTER
Providing Critical Information About the Industry
VISIT BIO.ORG
BIO Investor Forum Concludes
The BIO Investor Forum finished this week after hosting two days of expert-led panel discussions, fireside chats, over 165 company presentations and more than 2,750 individual meetings arranged through BIO One-on-One Partnering — a 26 percent increase over last year. The event was attended by more than 1,000 representatives of private and early stage biotech companies, leading investment firms, research organizations and others who came together to foster the development of new medical treatments and to grow the industry’s pipeline...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Blaming Pharma Won’t Lower Health Care Costs
HEALTH
spacer
Blaming Pharma Won’t Lower Health Care
Costs arrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO IP Counsels Committee Conference
spacer
Register for the BIO IP Counsels Committee Conferencearrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO IP Counsels Committee Conference
Double border
BIO Action Double border
HEALTH HEALTH
Misleading Reporting From 60 Minutes and the Washington Post
The scourge of opioid abuse is a growing public health crisis that has left no community in our nation untouched. It cuts across geographic, generational, political and economic divides, leaving in its wake countless victims, devastated families and economic ruin…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
New Infographic: The Bayh-Dole Act
The United States is the global leader in biomedical innovation, discovering more new cures than the rest of the world combined. We have brilliant scientists, world-class research institutions, and dedicated investors. But what sets us apart is a commitment to free-market policies that reward innovation and recognize the inherent costs and risks of discovering new treatments…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
International International
ONE HEALTH Event Discusses Solutions and Innovations in Biotechnology in Brazil
Joseph Damond, Executive Vice President of International Affairs at BIO led a keynote discussion on the challenges and opportunities of biotechnology innovation within Brazil. The keynote was part ONE HEALTH Innovative Biotech Solutions: Building Brazil’s Biotech Future, that took place on September 19 in São Paulo…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Event BIO Investor Forum
“Diverse Candidates Can Win If They Can Get the Interview.”
Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% of workers are female, but by the functional leader stage, that number tapers off to 30% and continues to fall to 16% at the CEO level. Ethnic representation in executive roles is just as bleak. As an industry, leadership that is more reflective of the people it serves will drive innovation and produce better business results…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
I&E Food & Agriculture
Celebrating our Farmers on #NationalFarmersDay!
On National Farmers Day, we celebrated the farmers and ag leaders who make our everyday life possible. While we don’t always think about how ag impacts our day to day lives, agriculture helps provide us with food, clothing, and shelter, as well as jobs. In fact, in 2015, 21 million full- and part-time jobs were related to agriculture – that’s around 11% of total U.S. employment!…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Bio Jobs
©2017 Biotechnology Innovation Organization. All rights reserved.
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising
FOLLOW US: Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Email us